Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease, Idiopathic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04957420
What this trial is testing

The Practical Effect of Neupro

Who this might be right for
Parkinson's Disease
Peking University Third Hospital 3,000
Post-approval studies (Phase 4)WithdrawnNCT00601978
What this trial is testing

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Who this might be right for
Parkinson's Disease
Novartis Pharmaceuticals
Not applicableStudy completedNCT01284699
What this trial is testing

Evaluation of the Safety and Efficacy of Bilateral Subthalamic Nucleus (SNT) Radiosurgery in Idiopathic Severe Parkinson's Disease Fulfilling Inclusion Criteria for STN Deep Brain Stimulation and Presenting With a Contraindication to Intracerebral Electrode Implantation.

Who this might be right for
Parkinson's DiseaseWith Inclusion Criteria for STN Deep Brain StimulationPresenting a Contraindication to Intracerebral Electrode Implantati
Assistance Publique Hopitaux De Marseille 14
Testing effectiveness (Phase 2)Study completedNCT00873392
What this trial is testing

Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Assistance Publique - Hôpitaux de Paris 40
Large-scale testing (Phase 3)Study completedNCT00505687
What this trial is testing

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma 186
Not applicableStudy completedNCT01807338
What this trial is testing

A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Sweden AB 11
Not applicableWithdrawnNCT04101513
What this trial is testing

The Natural History of Parkinson's Disease-associated Spinal Disorders

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Ohio State University
Not applicableStudy completedNCT05575479
What this trial is testing

PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson DiseaseIdiopathic Parkinson's Disease+3 more
Ohio State University 500
Large-scale testing (Phase 3)Study completedNCT01286935
What this trial is testing

18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 544
Testing effectiveness (Phase 2)UnknownNCT03683225
What this trial is testing

Evaluate in Patients With Parkinsonian Type Disorders

Who this might be right for
Idiopathic Parkinson Disease
Chase Therapeutics Corporation 24
Very early researchStudy completedNCT04202757
What this trial is testing

Intravenous Plasma Treatment for Parkinson's Disease

Who this might be right for
Idiopathic Parkinson Disease
The Neurology Center 22
Large-scale testing (Phase 3)Study completedNCT00244387
What this trial is testing

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Who this might be right for
Parkinson Disease, Idiopathic
UCB Pharma 506
Not applicableStudy completedNCT02627664
What this trial is testing

Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital, Lille 70
Testing effectiveness (Phase 2)Study completedNCT00296192
What this trial is testing

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms

Who this might be right for
Parkinson's Disease
UCB Pharma 82
Not applicableUnknownNCT02801110
What this trial is testing

PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
david groshar 40
Large-scale testing (Phase 3)Study completedNCT02352363
What this trial is testing

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 408
Not applicableUnknownNCT01190553
What this trial is testing

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

Who this might be right for
Parkinson Disease
Rabin Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT01856439
What this trial is testing

Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Axovant Sciences Ltd. 15
Post-approval studies (Phase 4)Study completedNCT01523301
What this trial is testing

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Who this might be right for
Idiopathic Parkinson's Disease
UCB Korea Co., Ltd. 380
Not applicableStudy completedNCT02248220
What this trial is testing

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 657
Next Page